abstract |
The present invention relates to compounds of formula (I), and salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compound inhibits Bcl-2 and / or Bcl-X L activity, which can be used for cancer therapy: ≪ Formula (I) > . |